Oramed Pharmaceuticals Inc.
ORMP
Rank in Stocks
#17484
Oramed Pharmaceuticals Inc., founded in 2002 and based in New York, New York,... Oramed Pharmaceuticals Inc., founded in 2002 and based in New York, New York, specializes in the development of groundbreaking pharmaceutical treatments. Their primary focus is on creating orally ingested capsules or pills for the delivery of polypeptides, particularly aimed at managing diabetes. The company's leading product, ORMD-0801, is an oral insulin capsule that has successfully completed Phase II clinical trials for patients with diabetes. Oramed is also advancing ORMD-0901, an oral glucagon-like peptide-1 (GLP-1) capsule, which has concluded Phase I clinical trials for the treatment of type 2 diabetes. Additionally, an oral leptin capsule for weight loss is currently under development. The firm was originally incorporated as Integrated Security Technologies, Inc., before officially changing its name to Oramed Pharmaceuticals Inc. in April 2006.
Share Price
$4.00
Last synced: 2026-11-09
Market Cap
$166.39M
Change (1 day)
3.63%
Change (1 year)
61.94%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Oramed Pharmaceuticals Inc. (ORMP)
Category
Healthcare
Dividend history for Oramed Pharmaceuticals Inc. (ORMP)
Oramed Pharmaceuticals Inc. (stock symbol: ORMP) made a total of 1 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $0.25
Dividend yield (TTM) : 6.08%
The sum of all dividends (adjusted for stock splits) is : $0.25
Dividend yield (TTM) : 6.08%
Dividend payments for Oramed Pharmaceuticals Inc. (ORMP) from 2026 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 67.00% |
AU
|
|
| 30.00% |
BE
|
|
| 0.00% |
NL
|
